Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer

BACKGROUND: Currently, there are no standard regimens for metastatic breast cancer patients (MBC) who have failed ≥ 3 chemotherapy treatments. The aim of this study was to assess whether weekly low‐dose bevacizumab‐based regimens were well tolerated and would improve efficacy in MBC patients who had...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Zhai, Xiaoyu, Hong, Ruoxi, Fan, Ying, Yuan, Peng, Wang, Jiayu, Sang, Die, Chen, Junlin, Zhao, Chunying, Ou, Kaiping, Ma, Fei, Xu, Binghe
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928366/
https://ncbi.nlm.nih.gov/pubmed/29575760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars